T.
ROWE
PRICE
New
Asia
Fund
July
31,
2021
(Unaudited)
1
Portfolio
of
Investments
‡
Shares
$
Value
(
Cost
and
value
in
$000s)
‡
CAYMAN
ISLANDS
0.3%
Common
Stocks
0.3%
ANT
International,
Class
C,
Acquisition
Date:
6/7/18,
Cost $10,313
(USD) (1)(2)(3)
1,838,333
12,960
Total
Cayman
Islands
(Cost
$10,313
)
12,960
CHINA
43.0%
Common
Stocks
32.2%
AAC
Technologies
Holdings
(HKD) (4)
3,375,500
20,260
Alibaba
Group
Holding
(HKD) (2)
4,268,544
104,250
Alibaba
Group
Holding,
ADR
(USD) (2)
417,837
81,558
Baidu,
ADR
(USD) (2)
153,400
25,159
Beijing
Capital
International
Airport,
H
Shares
(HKD) (2)
33,344,000
19,164
Beijing
Enterprises
Urban
Resources
Group
(HKD) (2)
42,116,000
4,606
China
Mengniu
Dairy
(HKD)
14,776,000
80,225
China
Resources
Gas
Group
(HKD)
16,112,000
99,327
China
Resources
Land
(HKD)
10,594,000
35,404
GDS
Holdings,
Class
A
(HKD) (2)
3,474,369
25,761
Greentown
Service
Group
(HKD)
35,216,000
38,337
Guangdong
Investment
(HKD)
24,738,000
34,615
Huazhu
Group,
ADR
(USD) (2)
1,003,900
45,155
I-Mab,
ADR
(USD) (2)
627,894
49,026
JOYY,
ADR
(USD)
423,800
22,652
Kanzhun,
ADR
(USD) (2)
197,000
6,787
KE
Holdings,
ADR
(USD) (2)
1,035,100
22,762
Keymed
Biosciences
(HKD) (2)
1,019,000
8,149
Meituan,
Class
B
(HKD) (2)
2,009,300
55,600
MINISO
Group
Holding,
ADR
(USD) (2)
971,521
16,409
New
Horizon
Health
(HKD) (2)
3,125,000
28,708
New
Oriental
Education
&
Technology
Group,
ADR
(USD) (2)
4,392,080
9,531
Pinduoduo,
ADR
(USD) (2)
284,785
26,089
Ping
An
Insurance
Group,
H
Shares
(HKD)
3,696,500
32,347
Shandong
Weigao
Group
Medical
Polymer,
H
Shares
(HKD)
34,020,000
61,039
Silergy
(TWD)
467,000
63,365
Sino
Biopharmaceutical
(HKD)
52,883,500
44,924
Tencent
Holdings
(HKD)
4,103,260
247,460
Tencent
Music
Entertainment
Group,
ADR
(USD) (2)
1,769,157
18,700
Wuxi
Biologics
Cayman
(HKD) (2)
1,400,500
21,392
1,348,761
Common
Stocks
-
China
A
Shares
10.8%
Deppon
Logistics,
A
Shares
(CNH)
16,176,834
24,591
Glodon,
A
Shares
(CNH)
4,879,545
47,761
T.
ROWE
PRICE
New
Asia
Fund
2
Shares
$
Value
(Cost
and
value
in
$000s)
Gree
Electric
Appliances
of
Zhuhai,
A
Shares
(CNH)
8,933,464
65,744
Hangzhou
Oxygen
Plant
Group,
A
Shares
(CNH)
6,049,215
32,609
Hongfa
Technology,
A
Shares
(CNH)
5,062,853
51,607
NARI
Technology,
A
Shares
(CNH)
18,658,574
90,870
NARI
Technology,
A
Shares (5)
8,167,382
39,779
Sangfor
Technologies,
A
Shares
(CNH)
991,425
37,282
Shenzhen
Inovance
Technology,
A
Shares
(CNH)
3,748,871
45,345
Yifeng
Pharmacy
Chain,
A
Shares
(CNH)
2,137,492
16,173
451,761
Total
China
(Cost
$1,504,233
)
1,800,522
HONG
KONG
7.6%
Common
Stocks
7.6%
AIA
Group
9,887,800
118,315
Budweiser
Brewing
APAC
7,197,200
20,086
Dairy
Farm
International
Holdings
(USD)
5,079,300
19,088
Galaxy
Entertainment
Group (2)
4,970,000
33,682
Health
&
Happiness
H&H
International
Holdings (4)
3,217,000
11,540
HKT
Trust
&
HKT
34,272,000
46,585
Sun
Hung
Kai
Properties
4,724,000
67,579
Total
Hong
Kong
(Cost
$235,758
)
316,875
INDIA
13.0%
Common
Stocks
13.0%
Bharat
Forge
2,980,021
31,038
Container
Corp.
of
India
3,814,523
33,091
Godrej
Consumer
Products (2)
1,491,030
19,897
HDFC
Bank
5,563,136
106,949
Housing
Development
Finance
1,153,841
38,006
Infosys
867,046
18,911
Infosys,
ADR
(USD)
6,547,691
144,835
Kotak
Mahindra
Bank (2)
3,813,521
85,120
Maruti
Suzuki
India
400,255
37,695
Voltas
1,637,399
23,361
Zomato (2)
374,583
677
Zomato,
Lockup
Shares (2)
3,687,255
6,329
Total
India
(Cost
$321,113
)
545,909
T.
ROWE
PRICE
New
Asia
Fund
3
Shares
$
Value
(Cost
and
value
in
$000s)
INDONESIA
1.0%
Common
Stocks
1.0%
Bank
Central
Asia
13,223,400
27,298
Unilever
Indonesia
52,081,900
15,212
Total
Indonesia
(Cost
$28,636
)
42,510
NETHERLANDS
1.9%
Common
Stocks
1.9%
ASML
Holding
(USD)
104,842
80,387
Total
Netherlands
(Cost
$32,622
)
80,387
PHILIPPINES
1.5%
Common
Stocks
1.5%
Bank
of
the
Philippine
Islands
9,089,640
14,658
Converge
ICT
Solutions (2)
53,571,990
24,436
Universal
Robina
9,871,470
25,033
Total
Philippines
(Cost
$62,753
)
64,127
SINGAPORE
3.3%
Common
Stocks
3.3%
ComfortDelGro
44,388,000
51,495
DBS
Group
Holdings
3,912,800
87,554
Total
Singapore
(Cost
$106,101
)
139,049
SOUTH
KOREA
6.7%
Common
Stocks
6.7%
Amorepacific
181,592
35,006
Coupang
(USD) (2)(4)
372,680
13,536
KakaoBank (2)
32,904
1,116
NAVER
158,315
59,669
Samsung
Electronics
2,513,986
171,797
Total
South
Korea
(Cost
$94,535
)
281,124
T.
ROWE
PRICE
New
Asia
Fund
4
Shares
$
Value
(Cost
and
value
in
$000s)
SWITZERLAND
1.7%
Common
Stocks
1.7%
Cie
Financiere
Richemont,
Class
A
563,396
72,097
Total
Switzerland
(Cost
$44,092
)
72,097
TAIWAN
16.3%
Common
Stocks
16.3%
Chailease
Holding
9,881,520
82,003
Hon
Hai
Precision
Industry
8,793,000
34,747
MediaTek
979,000
32,011
President
Chain
Store
5,113,000
51,357
Taiwan
Semiconductor
Manufacturing
20,538,574
429,246
Vanguard
International
Semiconductor
12,432,000
51,509
Total
Taiwan
(Cost
$290,803
)
680,873
THAILAND
1.8%
Common
Stocks
1.8%
CP
ALL
40,566,000
73,042
Total
Thailand
(Cost
$72,988
)
73,042
VIETNAM
0.7%
Common
Stocks
0.7%
Bank
for
Foreign
Trade
of
Vietnam
7,181,200
30,629
Total
Vietnam
(Cost
$33,498
)
30,629
SHORT-TERM
INVESTMENTS
0.5%
Money
Market
Funds
0.5%
T.
Rowe
Price
Government
Reserve
Fund,
0.04% (6)(7)
20,880,479
20,880
Total
Short-Term
Investments
(Cost
$20,880)
20,880
T.
ROWE
PRICE
New
Asia
Fund
5
Shares
$
Value
(Cost
and
value
in
$000s)
SECURITIES
LENDING
COLLATERAL
0.4%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
JPMORGAN
CHASE
BANK
0.4%
Short-Term
Funds
0.4%
T.
Rowe
Price
Short-Term
Fund,
0.07% (6)(7)
1,827,962
18,280
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
JPMorgan
Chase
Bank
18,280
Total
Securities
Lending
Collateral
(Cost
$18,280)
18,280
Total
Investments
in
Securities
99.7%
(Cost
$2,876,605)
$
4,179,264
Other
Assets
Less
Liabilities
0.3%
12,619
Net
Assets
100.0%
$
4,191,883
‡
Country
classifications
are
generally
based
on
MSCI
categories
or
another
unaffiliated
third
party
data
provider;
Shares
are
denominated
in
the
currency
of
the
country
presented
unless
otherwise
noted.
(1)
Level
3
in
fair
value
hierarchy.
(2)
Non-income
producing
(3)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
has
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$12,960
and
represents
0.3%
of
net
assets.
(4)
All
or
a
portion
of
this
security
is
on
loan
at
July
31,
2021.
(5)
China
A
shares
held
through
the
QFII
are
subject
to
certain
restrictions.
(6)
Seven-day
yield
(7)
Affiliated
Companies
ADR
American
Depositary
Receipts
CNH
Offshore
China
Renminbi
HKD
Hong
Kong
Dollar
TWD
Taiwan
Dollar
USD
U.S.
Dollar
T.
ROWE
PRICE
New
Asia
Fund
6
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
nine
months
ended
July
31,
2021.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
0.04%
$
—
$
—
$
23
T.
Rowe
Price
Short-Term
Fund,
0.07%
—
—
—++
Totals
$
—#
$
—
$
23+
Supplementary
Investment
Schedule
Affiliate
Value
10/31/20
Purchase
Cost
Sales
Cost
Value
07/31/21
T.
Rowe
Price
Government
Reserve
Fund,
0.04%
$
42,475
¤
¤
$
20,880
T.
Rowe
Price
Short-Term
Fund,
0.07%
13,192
¤
¤
18,280
Total
$
39,160^
#
Capital
gain
distributions
from
mutual
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees.
+
Investment
income
comprised
$23
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$39,160.
T.
ROWE
PRICE
New
Asia
Fund
Unaudited
Notes
to
Portfolio
of
Investments
7
T.
Rowe
Price
New
Asia
Fund (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as
an
open-end
management
investment
company
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus.
VALUATION
Fair
Value
The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The
T.
Rowe
Price
Valuation
Committee
(the
Valuation
Committee)
is
an
internal
committee
that
has
been
delegated
certain
responsibilities
by
the
fund’s
Board
of
Directors
(the
Board)
to
ensure
that
financial
instruments
are
appropriately
priced
at
fair
value
in
accordance
with
GAAP
and
the
1940
Act.
Subject
to
oversight
by
the
Board,
the
Valuation
Committee
develops
and
oversees
pricing-related
policies
and
procedures
and
approves
all
fair
value
determinations.
Specifically,
the
Valuation
Committee
establishes
policies
and
procedures
used
in
valuing
financial
instruments,
including
those
which
cannot
be
valued
in
accordance
with
normal
procedures
or
using
pricing
vendors;
determines
pricing
techniques,
sources,
and
persons
eligible
to
effect
fair
value
pricing
actions;
evaluates
the
services
and
performance
of
the
pricing
vendors;
oversees
the
pricing
process
to
ensure
policies
and
procedures
are
being
followed;
and
provides
guidance
on
internal
controls
and
valuation-related
matters.
The
Valuation
Committee
provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
T.
ROWE
PRICE
New
Asia
Fund
8
Level
2
–
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
–
unobservable
inputs
(including
the fund’s
own
assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the
fund
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
its
portfolio
securities.
Each
business
day,
the
fund
uses
information
from
outside
pricing
services
to
evaluate
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The
fund
uses
outside
pricing
services
T.
ROWE
PRICE
New
Asia
Fund
9
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The
fund
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Investments
for
which
market
quotations
or
market-based
valuations
are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Committee,
in
accordance
with
fair
valuation
policies
and
procedures.
The
objective
of
any
fair
value
pricing
determination
is
to
arrive
at
a
price
that
could
reasonably
be
expected
from
a
current
sale.
Financial
instruments
fair
valued
by
the
Valuation
Committee
are
primarily
private
placements,
restricted
securities,
warrants,
rights,
and
other
securities
that
are
not
publicly
traded.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Committee
typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Committee
may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis
and
updated
as
information
becomes
available,
including
actual
purchase
and
sale
transactions
of
the
investment.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions,
and
fair
value
prices
determined
by
the
Valuation
Committee
could
differ
from
those
of
other
market
participants.
T.
ROWE
PRICE
New
Asia
Fund
10
Valuation
Inputs
The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
July
31,
2021
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
F39-054Q3
07/21
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
562,586
$
3,564,558
$
12,960
$
4,140,104
Short-Term
Investments
20,880
—
—
20,880
Securities
Lending
Collateral
18,280
—
—
18,280
Total
$
601,746
$
3,564,558
$
12,960
$
4,179,264